ITI Pharma and Healthcare Fund - Dir (G) logo

ITI Pharma and Healthcare Fund Direct Growth

NAV ₹17.70 as on 17 Nov 2025

RiskVery High

Fund Size₹232.83Cr

NAV₹17.70 as on 17 Nov 2025
RiskVery High
Fund Size₹232.83Cr

Download 3-in-1 Torus App
Trade at flat ₹11/order & Zero AMC
demat with one powerful SuperApp.

Investment Details
Top Rated Funds

Lock-in

No Lock-in

Min One Time Amount

₹5,000

Min Withdrawal Amount

₹-

Min SIP Amount

₹500

Min Additional Amount

₹1,000

Exit Load

If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL

Basic Details

Age

4 years 0 months (Since Nov 08, 2021)

Return since Launch

15.22%

Expense ratio

0.47%

Type

OPEN

AUM (Fund Size)

₹232.83

Risk Grade

Very High

Benchmark

NIFTY Healthcare TRI

Calculate Your Returns
Select Duration
Choose Amount
Returns
Total investment of ₹2,40,000
Would have become ₹61,949 (+209.74%)
Fund Manager

Name:

Rohan Korde

Experience:

He has joined ITI Asset Management Limited (ITIAML) in June 2019 and has over 17 years of work experience in capital markets. His focus has been on fundamental research on investment ideas across various sectors and industries. Past Experience: September 2017 - May 2019 with BOB Capital Markets as Vice President Research February 2015 - August 2017 with Prabhudas Lilladher as Vice President Research February 2009 - February 2015 with Anand Rathi Share & Stock Brokers as Vice President Research

RiskometerLevel of risk in the scheme
Moderate
High
Low
Very
High

Your investment will be at Very High Risk

Fund house & investment objective
Rank (total assets)#33 in India
Total AUM₹10,715.38Cr
Date of Incorporation10 Jan 2008
ITI Pharma and Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by ITI Mutual Fund. This scheme was made available to investors on 08 Nov 2021. The fund currently has an Asset Under Management(AUM) of ₹10,715.38 Cr and the Latest NAV as of 17 Nov 2025 is ₹17.70.
The ITI Pharma and Healthcare Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹500 . Minimum Lumpsum Investment is ₹5,000. Exit load of If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL.
...Read more
Returns and Rankings

Category: Equity Sectoral / Thematic

1Y3Y5YAll
Fund returns0.96%6.78%-3.61%
Category average8.02%6.14%3.98%-
Rank within category1664595-

FAQ’s

What kind of returns does ITI Pharma and Healthcare Fund Direct Growth provide?

ITI Pharma and Healthcare Fund Direct Growth has given a return of 21.73% in the past 3 years.

What is the expense ratio charged by ITI Pharma and Healthcare Fund Direct Growth?

The Expense Ratio charged by ITI Pharma and Healthcare Fund Direct Growth is 0.47%.

What is the AUM size of ITI Pharma and Healthcare Fund Direct Growth?

The AUM size of ITI Pharma and Healthcare Fund Direct Growth is ₹232.83Cr.

What is the minimum SIP amount that you can invest in ITI Pharma and Healthcare Fund Direct Growth?

₹500 is the minimum SIP amount that you can invest in ITI Pharma and Healthcare Fund Direct Growth .

What are the top stock holdings of ITI Pharma and Healthcare Fund Direct Growth?

The top stock holdings of ITI Pharma and Healthcare Fund Direct Growth include , Sun Pharmaceutical Industries Ltd , Divis Laboratories Ltd , Torrent Pharmaceuticals Ltd and Cohance Lifesciences Ltd.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.